{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
mmae
to a specific field?
Status:
Investigational
Source:
INN:samrotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:zilovertamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:mecbotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:disitamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ozuriftamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:enapotamab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:sirtratumab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:iladatuzumab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ladiratuzumab vedotin [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:vandortuzumab vedotin [INN]
Source URL:
Class:
PROTEIN